Malignant transformation in inflammatory bowel disease - surveillance guide

Area of Science:

• Gastroenterology
• Oncology
• Inflammatory Bowel Disease Research

Background:

• Patients with long-standing ulcerative colitis (UC) and Crohn's disease (CD) have an increased risk of colorectal cancer (CRC).
• Current cancer prevention strategies for inflammatory bowel disease (IBD) focus on the inflammation-neoplasia-carcinoma sequence.
• Colonoscopic surveillance with biopsies is recommended for early neoplasia detection in IBD patients.

Purpose of the Study:

• To evaluate the effectiveness of current colonoscopic surveillance strategies for detecting early colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD).
• To assess the impact of novel endoscopic techniques on neoplasia detection rates.
• To determine if existing surveillance guidelines need restructuring based on new data.

Main Methods:

• Review of existing data on CRC risk in UC and CD patients.
• Analysis of the efficacy of colonoscopic surveillance, including random and targeted biopsies.
• Evaluation of novel endoscopic techniques like chromoendoscopy and narrow band imaging for enhanced neoplasia detection.

Main Results:

• Novel endoscopic techniques show promise in enhancing neoplasia detection.
• There is limited direct evidence that current surveillance strategies effectively reduce CRC mortality in IBD.
• Surveillance based on disease duration has delayed or missed diagnoses of early CRC in a significant number of patients.

Conclusions:

• Current colonoscopic surveillance guidelines for IBD patients appear insufficient for timely early CRC detection.
• Restructuring of surveillance strategies is necessary to improve outcomes for high-risk IBD populations.
• Further research is needed to validate the effectiveness of enhanced surveillance techniques in reducing CRC mortality.